v3.26.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Feb. 26, 2026
Apr. 01, 2025
Aug. 30, 2023
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Fair value       $ 82,600   $ 176,500
Unrealized gain (loss)       (100)   $ 100
Amortized cost       58,600    
Debt securities mature within one year       105,000    
Debt securities mature within year one through five       36,100    
Estimated proceeds from sale of priority review voucher $ 150,000          
Proceeds from sale of PRV   $ 148,300        
Inventory write-down       $ 485 $ 0  
Commave Settlement Agreement            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Royalty percentage       10.00%    
Acer and Relief Therapeutics SA | License | Relief License Agreement            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Royalty percentage     10.00%      
Contractual obligation     $ 45,000      
Acer and Relief Therapeutics SA | License | Relief License Agreement | Maximum            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Contractual obligation     $ 56,500